Free Trial
NASDAQ:HROW

Harrow (HROW) Stock Price, News & Analysis

Harrow logo
$34.37 -1.25 (-3.51%)
Closing price 04:00 PM Eastern
Extended Trading
$34.47 +0.10 (+0.28%)
As of 06:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Harrow Stock (NASDAQ:HROW)

Key Stats

Today's Range
$33.85
$35.71
50-Day Range
$23.59
$34.93
52-Week Range
$20.85
$59.23
Volume
534,967 shs
Average Volume
498,399 shs
Market Capitalization
$1.26 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$63.83
Consensus Rating
Buy

Company Overview

Harrow Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

HROW MarketRank™: 

Harrow scored higher than 44% of companies evaluated by MarketBeat, and ranked 649th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Harrow has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Harrow has only been the subject of 4 research reports in the past 90 days.

  • Read more about Harrow's stock forecast and price target.
  • Earnings Growth

    Earnings for Harrow are expected to grow in the coming year, from ($0.53) to $0.40 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Harrow is -61.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Harrow is -61.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Harrow has a P/B Ratio of 17.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Harrow's valuation and earnings.
  • Percentage of Shares Shorted

    13.27% of the float of Harrow has been sold short.
  • Short Interest Ratio / Days to Cover

    Harrow has a short interest ratio ("days to cover") of 9.5.
  • Change versus previous month

    Short interest in Harrow has recently increased by 1.72%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Harrow does not currently pay a dividend.

  • Dividend Growth

    Harrow does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.27% of the float of Harrow has been sold short.
  • Short Interest Ratio / Days to Cover

    Harrow has a short interest ratio ("days to cover") of 9.5.
  • Change versus previous month

    Short interest in Harrow has recently increased by 1.72%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Harrow has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for Harrow this week, compared to 5 articles on an average week.
  • Search Interest

    Only 4 people have searched for HROW on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Harrow insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    13.67% of the stock of Harrow is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    72.76% of the stock of Harrow is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Harrow's insider trading history.
Receive HROW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Harrow and its competitors with MarketBeat's FREE daily newsletter.

HROW Stock News Headlines

Cantor Fitzgerald Initiates Coverage on Harrow (NASDAQ:HROW)
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
Harrow: Immense Upside Potential
See More Headlines

HROW Stock Analysis - Frequently Asked Questions

Harrow's stock was trading at $33.55 at the start of the year. Since then, HROW shares have increased by 2.4% and is now trading at $34.37.

Harrow, Inc. (NASDAQ:HROW) issued its quarterly earnings results on Thursday, May, 8th. The company reported ($0.38) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by $0.40. The firm had revenue of $47.83 million for the quarter, compared to analysts' expectations of $57 million. Harrow had a negative net margin of 10.19% and a negative trailing twelve-month return on equity of 25.01%.
Read the conference call transcript
.

Harrow's top institutional shareholders include SJS Investment Consulting Inc. (0.02%). Insiders that own company stock include Opaleye Management Inc, Mark L Baum, Andrew R Boll, Martin A Makary, Richard L Md Lindstrom and Horn R Lawrence Van.
View institutional ownership trends
.

Shares of HROW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Harrow investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Visa (V), Netflix (NFLX) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
5/08/2025
Today
7/15/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HROW
Previous Symbol
NASDAQ:HROW
CIK
1360214
Employees
180
Year Founded
N/A

Price Target and Rating

High Price Target
$76.00
Low Price Target
$55.00
Potential Upside/Downside
+82.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.56)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$17.48 million
Net Margins
-10.19%
Pretax Margin
-10.12%
Return on Equity
-25.01%
Return on Assets
-4.27%

Debt

Debt-to-Equity Ratio
2.01
Current Ratio
0.91
Quick Ratio
0.85

Sales & Book Value

Annual Sales
$199.61 million
Price / Sales
6.44
Cash Flow
$0.14 per share
Price / Cash Flow
255.45
Book Value
$1.95 per share
Price / Book
17.98

Miscellaneous

Outstanding Shares
36,690,000
Free Float
31,670,000
Market Cap
$1.29 billion
Optionable
Optionable
Beta
0.41
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:HROW) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners